收藏切换
Susceptible factors for liver injury after R-CHOP chemotherapy in non-Hodgkin lymphoma patients and preventive hepatoprotective effect of magnesium isoglycyrrhizinate
收藏切换
Renjun BAO1, 2, Xuanfu XU3, Wenhui MO3, *
World Clinical Drug | 2022, 43(10) : 1362 - 1368
Less
收藏切换
World Clinical Drug | 2022, 43(10): 1362-1368
• Article •
Susceptible factors for liver injury after R-CHOP chemotherapy in non-Hodgkin lymphoma patients and preventive hepatoprotective effect of magnesium isoglycyrrhizinate
Full
Renjun BAO1, 2, Xuanfu XU3, Wenhui MO3, *
Affiliations
  • 1.Suzhou Medical College of Soochow University, Suzhou 215123, Jiangsu Province, China
  • 2.Department of Hematology, Shidong Hospital, Yangpu District (Shidong Hospital Affiliated to University of Shanghai for Science and Technology), Shanghai 200438, China
  • 3.Department of Gastroenterology, Shidong Hospital, Yangpu District (Shidong Hospital Affiliated to University of Shanghai for Science and Technology), Shanghai 200438, China
Published: 2022-10-10 doi: 10.13683/j.wph.2022.10.021
Outline
收藏切换
Objective

To investigate the susceptible factors of liver injury after chemotherapy with R-CHOP (rituximab+cyclophosphamide+doxorubicin hydrochloride liposome injection+oncovin+prednisone) in non-Hodgkin lymphoma (NHL) patients, and to observe the hepatoprotective effect of prophylactic magnesium isocyanate.

Methods

The clinical data of 328 NHL patients who met the diagnostic criteria were collected and analyzed from January 1, 2016 to December 31, 2021 in the Department of Hematology, Shidong Hospital, Yangpu District, Shanghai. According to whether hepatoprotective treatment was used in chemotherapy, the patients were divided into two groups according to whether or not hepatoprotective treatment. First, the liver injury patients were determined in the group of unprotected liver patients, and the susceptible factors for liver injury after R-CHOP chemotherapy were analyzed. Then all patients were divided into four groups: non-susceptible factors without liver protection group (A group), susceptible factors without liver protection group (B group), non-susceptible factors with liver protection group (C group), susceptible factor with liver protection group (D group). Groups C and D were treated with magnesium isoglycyrrhizinate for liver protection. The incidence of liver injury and the changes of liver function indexes alanine aminotransferase (ALT), alkaline phosphatase (ALP) and (total bilirubin, TBiL)] of all patients before and after chemotherapy were compared and statistically analyzed.

Results

Alcohol consumption, non-alcoholic fatty liver disease, HBV carriers, and lymphoma liver infiltration were found to be independent susceptible factors for liver injury in NHL patients after R-CHOP chemotherapy. There was no significant difference in the incidence of liver injury (8.13%/5.48%) among the patients without susceptibility factors, while in the patients with susceptibility factors, the incidence of liver injury in the liver protection patients was significantly reduced (7.55%/40.51%). The levels of ALT, ALP and TBiL in patients with susceptibility factors were higher than those without susceptibility factors, and the differences were statistically significant (P<0.05).

Conclusion

Alcohol consumption, non-alcoholic fatty liver disease, HBV carriers and liver infiltration of lymphoma are independent susceptible factors for liver injury in NHL patients after R-CHOP chemotherapy. For NHL patients with the above susceptible factors, magnesium isoglycyrrhizinate can be used to protect the liver effectively during R-CHOP chemotherapy.

non-Hodgkin lymphoma  /  R-CHOP  /  liver injury  /  susceptible factors  /  magnesium isoglycyrrhizinate
包仁君, 徐选福, 莫文辉. 非霍奇金淋巴瘤患者R-CHOP化疗后肝损伤的易感因素及异甘草酸镁预防性保肝作用研究. 世界临床药物, 2022 , 43 (10) : 1362 -1368 . DOI: 10.13683/j.wph.2022.10.021
Renjun BAO, Xuanfu XU, Wenhui MO. Susceptible factors for liver injury after R-CHOP chemotherapy in non-Hodgkin lymphoma patients and preventive hepatoprotective effect of magnesium isoglycyrrhizinate[J]. World Clinical Drug, 2022 , 43 (10) : 1362 -1368 . DOI: 10.13683/j.wph.2022.10.021
Year 2022 volume 43 Issue 10
7
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.10.021
  • Receive Date:2022-05-12
  • Online Date:2026-11-18
  • Published:2022-10-10
Article Data
Affiliations
History
  • Received:2022-05-12
Affiliations
    1.Suzhou Medical College of Soochow University, Suzhou 215123, Jiangsu Province, China
    2.Department of Hematology, Shidong Hospital, Yangpu District (Shidong Hospital Affiliated to University of Shanghai for Science and Technology), Shanghai 200438, China
    3.Department of Gastroenterology, Shidong Hospital, Yangpu District (Shidong Hospital Affiliated to University of Shanghai for Science and Technology), Shanghai 200438, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.10.021
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT